Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors
  • Program Overview
    Therapeutic Strategies With Selective CDK4/6 Inhibitors: An Oncologist’s Guide to Safe Inhibition of Uncontrolled Cellular Proliferation in Solid Tumors
    Review recent developments with selective CDK4/6 inhibitors in the care of patients with various cancers in this certified text module, on-demand Webcast, and accompanying slideset developed by Richard Finn, MD; Geoffrey Shapiro, MD, PhD; and Gary K. Schwartz, MD.
  • Featured content
    The first of 3 downloadable slidesets from a satellite symposium at the 2017 annual meeting in Chicago: Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, review critical data on the mechanisms of CDK4/6 inhibition and its clinical effects in various cancer types.
    Date Posted: 6/8/2017
  • Featured content
    Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
  • 1
  • 2
  • 3

Latest Content

6 of 6 Shown
6 of 6 Shown
Show 0 More
Loading...